Bio Green Med Solution, Inc. reported Q1 2026 revenue of $778,000, a significant increase from $0 in Q1 2025, reflecting its strategic shift from biopharmaceuticals to fire safety protection following the acquisition of Fitters Sdn. Bhd. The company's preferred stock was delisted from Nasdaq on March 23, 2026, though its common stock remains listed. Despite improved operating loss, the net loss applicable to common shareholders increased to $217,000 due to the absence of a large deconsolidation gain seen in the prior year. The company also noted substantial doubt about its ability to continue as a going concern beyond Q4 2026 without additional financing.